Artelo Biosciences, Inc. ARTL
2.21 USD +0.07 (+3.16%)
Nov 11, 2026, 11:11 AM EST
2.14 Day range 2.26
1.91 52-week range 179.19
- YTD
- -93.29%
- 1 year
- -95.82%
News
benzinga.com Artelo Biosciences To Present Data For Its ART27.13 To Treat Chemotherapy-Induced Neuropathic Pain At IASP 2026 World Congress On Pain Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with
benzinga.com Artelo Bioscience To Present Data On ART26.12 Program At IASP 2026 World Congress On Pain, October 26–30; Growing Body Of Data Supports ART26.12’s Potential As A Novel, Non-Opioid Treatment For Pain Ahead Of Planned Multiple Ascending Dose Study Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Firefly Neuroscience (NASDAQ:AIFF) shares increased by 33.2% to $1.58 during Friday's regular session. The company's market cap stands at $18.6 million. Apimeds Pharmaceuticals (AMEX:APUS)…
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares increased by 162.4% to $6.01 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million. Surrozen…
benzinga.com Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000 U.S. stocks fell Thursday as tech slid; jobless claims beat estimates. Oil rose, while APUS surged 245% and BENF plunged 33%.- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million. GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to…
benzinga.com Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket GlucoTrack surged 117.7% premarket after Lokahi Therapeutics signed its first external partnership; other stocks saw notable gains and losses.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines…
benzinga.com Artelo Biosciences (ARTL) Stock Surges Wednesday: What's Happening? Artelo Biosciences, Inc. (NASDAQ: ARTL) shares are surging Wednesday afternoon after the clinical-stage biopharmaceutical company announced the filing of a new provisional patent application covering…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 216.1% to $13.12 during Wednesday's regular session. The market value of their outstanding shares is at $2.2 million. Vistagen Therapeutics…
benzinga.com Artelo Biosciences Files Provisional Patent Application For ART27.13 As Monotherapy And In Combination With GLP-1 Receptor Agonists As reported, ART27.13 produced approximately 40% weight loss in combination with semaglutide and approximately 20% as monotherapy, comparable to semaglutide, in obese mice over four weeksApplication…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 354.9% to $7.37 during Wednesday's regular session. The company's market cap stands at $4.9 million. Q/C Technologies (NASDAQ:QCLS) shares…
benzinga.com Artelo Cannabinoid Drug Doubles Weight Loss When Paired with Popular Obesity Drug Artelo Biosciences shares new nonclinical data showing its oral cannabinoid drug ART27.13 matches semaglutide weight loss in obese mice.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market session. The company's market cap stands at $4.9 million. Tempest Therapeutics (NASDAQ:TPST) stock moved…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million. Akanda (NASDAQ:AKAN) shares increased by 27.52% to…
benzinga.com Artelo Biosciences Announces 1-For-9 Reverse Stock Split, Effective August 31 Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with
benzinga.com Artelo Biosciences Issued Notification Of Allowance From Japanese Patent Office With Decision To Grant Patent Application For Commercial Formulation Of ART27.13 Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living…
benzinga.com Artelo Biosciences Says USPTO Issues Notice Of Allowance For U.S. Patent Application Covering Intended Commercial Formulation Of ART27.13, Peripherally Selective Cannabinoid Agonist Currently In Phase 2 Studies The Patent Claims are for the Intended Commercial Formulation of ART27.13Expected to Extend Patent Protection for ART27.13 through 2041SOLANA BEACH, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Artelo…- benzinga.com Artelo Biosciences Q2 EPS $(0.89) Up From $(16.83) YoY Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.89) per share. This is a 94.71 percent increase over losses of $(16.83) per share from the same period last year.
benzinga.com Artelo Biosciences Says First Patient Dosed In DREAM Study Evaluating Effects Of ART27.13 In Patients With Glaucoma Or Ocular Hypertension; Initial DREAM Study Results Anticipated In Q4 Investigator-led study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmologyInitial DREAM Study Results Anticipated in Q4 2026SOLANA BEACH, Calif.,…
benzinga.com Artelo Biosciences Announces Publication Of Article 'Evaluating The Pharmacokinetics, Efficacy, And Safety Of Low Dose Cannabidiol' In The British Journal Of Clinical Pharmacology The peer-reviewed evaluation analyzed the efficacy, pharmacokinetics, and safety data obtained from over 50 studies using low-dose cannabidiol (CBD) commonly found in over-the-counter products — and…- benzinga.com Artelo Biosciences Announces Oral Administration Of ART26.12 Lowers Osteoarthritis-Associated Pain Behaviors Over 4-Week Testing; Shows Efficacy To Naproxen Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market session. The market value of their outstanding shares is at $2.6 million. China Pharma Holding (AMEX:CPHI)…
- benzinga.com Artelo Biosciences Reports Preclinical Results For ART27.13 in Cancer-Related Neuropathic Pain; Findings Suggest Broader Utility In Cancer Supportive Care, Building On Interim Findings From CAReS Phase 2 Clinical Study Which Demonstrated Improvements In Body Weight, Lean Body Mass And Activity Levels Expands potential benefit for treating neuropathic pain in cancer patients, particularly those experiencing weight loss due to cancerFindings suggest broader utility in cancer supportive care,…
- benzinga.com Artelo Biosciences Announces Data From Preclinical Trial In Neuropathic Pain From Spinal Cord Injury Shows Lowered Mechanical Hypersensitivity Associated With Nerve Injury; Decreased Spontaneous Pain-Related Behaviors Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with
- benzinga.com Artelo Biosciences Identifies Lipid Pathway Link For ART26.12 In Multi-Omics Cancer Research Presentation At The CRS 2026 Annual Symposium Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to develop treatments for people living with cancer, pain,…
- benzinga.com Artelo Biosciences Announces Two Presentations Supporting Development Of ART26.12, Its Selective Fatty Acid Binding Protein 5 Inhibitor The presentations include results from the Phase 1 clinical study of ART26.12 as well as new biomarker analyses designed to identify indicators of target engagement and pharmacological activity in…
- benzinga.com Artelo Biosciences Presents Metabolite Identification And Profiling Data From Its FABP Inhibitor Candidate ART26.12; Tracks Three Metabolites From Plasma Of Healthy Volunteers Given Single 900 Mg Oral Dose Of ART26.12 Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with…
benzinga.com Crude Oil Falls Over 5%; Dycom Industries Shares Surge Following Q1 Results U.S. stocks traded mixed, Nasdaq down 0.3%. Dow up 0.59%, S&P 500 down 0.09%. Consumer discretionary shares up 1.9%. Dycom Industries reports strong earnings.
benzinga.com Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results US stocks mixed, Dow up 300 pts. Dow up 0.64%, NASDAQ down 0.34%. Consumer discretionary up 1.7%, energy down 1.9%. DKS stock falls 5% on mixed results.
benzinga.com Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares rose 7% in pre-market trading as Q2 guidance exceeded expectations.- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, CODX +22.7%, MDAI +22%. Losers: AKTX -25.2%, RYOJ -18.6%, DEVS -18.6%, AKAN -17%, ADTX -16.3%, LFS…- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $2.2 billion. Other gainers include SBFM, NXXT, GOVX, CREG, PMI, ZDAI, GCTS, CMPS, and DXYZ. BTM,…- benzinga.com Artelo Biosciences Q1 EPS $(4.00) Misses $(1.57) Estimate Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(4.00) per share which missed the analyst consensus estimate of $(1.57) by 154.78 percent. This is a 69.14 percent increase over losses…
benzinga.com Artelo Biosciences Files Prospectus For Offering $75M Mixed Shelf https://www.sec.gov/Archives/edgar/data/1621221/000164033426000820/artl_s3.htm- benzinga.com Artelo Biosciences Collaborates With ScienceMachine Over Development Of Its Fatty Acid-Binding Protein 5 Inhibitor Platform Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain,…
benzinga.com What's Behind The Rise In Artelo Biosciences Stock? Artelo Biosciences, Inc. (NASDAQ:ARTL) shares jumped on Monday after the company announced the publication of a peer‑reviewed article highlighting FABP5 as a therapeutic target for pain.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com Artelo Biosciences Announces Publication Of Peer‑Reviewed Article On FABP5 As Therapeutic Target For Pain Management In European Journal Of Pain Demonstrates ART26.12's Differentiated Profile as a Promising Pain Treatment Ahead of Planned Multiple Ascending Dose Study This YearPhase 1 SAD Study Exhibited Excellent Safety with Zero Adverse…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com EXCLUSIVE: Top 12 Most-Searched Tickers On Benzinga Pro In March – Where Do Tesla, Nvidia, Micron Stocks Rank? A look at the most-searched tickers on Benzinga Pro for the month of March shows several newcomers and momentum stocks that saw strong interest.
benzinga.com Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its second SpaceShip is expected to enter service soon, causing a 6% jump in pre-market trading. Other…- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Avis Budget Group, Toyota Motor And Other Big Stocks Moving Lower In Monday's Pre-Market Session U.S. stock futures up, Dow gains 150 points. Avis Budget Group (CAR) shares fall 9.6% in pre-market. Other stocks lower in pre-market trading.
benzinga.com Why PMGC Holdings Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket PMGC Holdings shares surged 100.6% to $3.35 in pre-market trading after announcing a licensing agreement amendment for its clinical development program. Gainers include ITRM, ZNB, and GV; Losers…